Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
- PMID: 36660010
- PMCID: PMC9839229
- DOI: 10.1097/CCE.0000000000000839
Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
Abstract
Critical care pharmacists when incorporated into the ICU team, have been shown to improve outcomes in critically ill patients by decreasing mortality, improving morbidity and reducing cost. As telehealth continues to evolve, the incorporation of a critical care pharmacist into a comprehensive telecritical care (TCC) service will allow increased comprehensive pharmacotherapeutic care for those in smaller, community or rural hospitals.
Objectives: To describe the implementation of a TCC pharmacist into an established TCC network, classify interventions performed, and quantify cost avoidance generated through pharmacist interventions.
Design: Multicenter, observational cohort study and retrospective return on investment, performed between December 2019 and December 2021.
Setting and participants: Critically ill adult patients, admitted to an ICU located in any of our eight community hospitals (50 ICU beds) within a large, 25-hospital integrated healthcare system (563 ICU beds total) in the United States.
Main outcomes and measures: The TCC pharmacist service was implemented in 8-hour shifts, initially available 5 days per week, then expanded to 7 days per week. Critical care pharmacist interventions were categorized by clinical type established utilizing American Society of Health-System Pharmacists benchmarking standards and the latest cost avoidance data.
Results: During the 2-year analysis period, TCC pharmacists documented 2,838 interventions generating $1,664,254 of gross cost avoidance and a return on investment of 4.5:1.
Conclusions and relevance: It is feasible to implement a TCC pharmacist within an established TCC network. Our experience showed enhanced comprehensive care of critically ill patients located in community hospitals within a large, integrated healthcare system, demonstrated significant cost avoidance, and has led to other initiatives, including a collaborative clinical/operational partnership with Life Flight.
Keywords: cost avoidance; critical care; intensive care unit; pharmacy; telecritical care; telehealth; telepharmacy.
Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Similar articles
-
PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.Crit Care Explor. 2021 Dec 10;3(12):e0594. doi: 10.1097/CCE.0000000000000594. eCollection 2021 Dec. Crit Care Explor. 2021. PMID: 34913039 Free PMC article.
-
Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study.Crit Care Explor. 2023 Oct 5;5(10):e0980. doi: 10.1097/CCE.0000000000000980. eCollection 2023 Oct. Crit Care Explor. 2023. PMID: 37811129 Free PMC article.
-
Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score.Crit Care Med. 2022 Sep 1;50(9):1318-1328. doi: 10.1097/CCM.0000000000005585. Epub 2022 Aug 15. Crit Care Med. 2022. PMID: 35678204 Free PMC article.
-
Pharmacist contributions as members of the multidisciplinary ICU team.Chest. 2013 Nov;144(5):1687-1695. doi: 10.1378/chest.12-1615. Chest. 2013. PMID: 24189862 Review.
-
Current practices and state regulations regarding telepharmacy in rural hospitals.Am J Health Syst Pharm. 2010 Jul 1;67(13):1085-92. doi: 10.2146/ajhp090531. Am J Health Syst Pharm. 2010. PMID: 20554595 Review.
Cited by
-
Continuing excellence in critical care pharmacy practice, education, and advocacy.J Am Coll Clin Pharm. 2023 Aug;6(8):840-842. doi: 10.1002/jac5.1852. Epub 2023 Aug 2. J Am Coll Clin Pharm. 2023. PMID: 37614698 Free PMC article. No abstract available.
-
Impact of Clinical Pharmacist Intervention in the Intensive Care Unit, Wad Medani, Sudan: A Cross-Sectional, Prospective Study.Integr Pharm Res Pract. 2024 May 9;13:43-49. doi: 10.2147/IPRP.S459170. eCollection 2024. Integr Pharm Res Pract. 2024. PMID: 38741594 Free PMC article.
References
-
- Weiss B, Paul N, Balzer F, et al. : Telemedicine in the intensive care unit: A vehicle to improve quality of care. J Crit Care 2021; 61:241–246 - PubMed
-
- Lilly CM, Greenberg B: The evolution of tele-ICU to tele-critical care. Crit Care Med 2020; 48:610–611 - PubMed
-
- Subramanian S, Pamplin JC, Hravnak M, et al. : Tele-critical care: An update from the Society of Critical Care Medicine Tele-ICU committee. Crit Care Med 2020; 48:553–561 - PubMed
-
- Forni A, Skehan N, Hartman CA, et al. : Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients. Ann Pharmacother 2010; 44:432–438 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials